FAM
BIO icon

Fred Alger Management’s Bio-Rad Laboratories Class A BIO Stock Holding History

Fred Alger Management’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,083
Closed -$261K – 455
2025
Q2 		$261K Buy
1,083
+89
+9% +$21K ﹤0.01% 405
2025
Q1 		$242K Buy
+994
New +$299K ﹤0.01% 405
2020
Q3 		– Sell
-11,612
Closed -$5.24M – 468
2020
Q2 		$5.24M Buy
11,612
+1,986
+21% +$876K 0.02% 224
2020
Q1 		$3.37M Buy
9,626
+2,306
+32% +$848K 0.01% 237
2019
Q4 		$2.71M Buy
7,320
+3,320
+83% +$1.17M 0.01% 275
2019
Q3 		$1.33M Buy
+4,000
New +$1.3M 0.01% 313

Other funds holding BIO

First Eagle Investment Management
First Eagle Investment Management New York $60.8B AUM 26.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.56B AUM 3.46% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fred Alger Management's BIO Position: Q3 2025 in Review

Fred Alger Management sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2025, closing a stake of 1,083 shares — an estimated $261K sold.

Fred Alger Management first reported a position in BIO in Q3 2019 and held it in 6 quarters. The position peaked at $5.24M in Q2 2020. 397 funds tracked by Wall St. Rank hold BIO as of Q3 2025.

  • Fred Alger Management reported no remaining Bio-Rad Laboratories Class A position as of Q3 2025 after selling out during the quarter.
  • Fred Alger Management sold 1,083 Bio-Rad Laboratories Class A shares in Q3 2025, an estimated $261K.
  • Fred Alger Management first reported a position in Bio-Rad Laboratories Class A in Q3 2019 and held it in 6 quarters.
  • Fred Alger Management's Bio-Rad Laboratories Class A position peaked at $5.24M in Q2 2020.
  • 397 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2025.

Based on Fred Alger Management's 13F filing for Q3 2025, filed 14 Nov 2025.